Stephen C Piscitelli

5PUBLICATIONS
30CO-AUTHORS
Epidemiological methodsInfant and child healthAvionicsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 22, 2025
Tapinarof Cream for Adults and Children with Atopic Dermatitis-Efficacy by Race and Fitzpatrick Skin Type in Two Phase 3 Randomized Clinical Trials.

Andrew F Alexis, Leon Kircik, Raj Chovatiya

|Mar 24, 2025
Maximal Usage Trial of Tapinarof Cream 1% Once Daily in Pediatric Patients Down to 2 Years of Age with Extensive Atopic Dermatitis.

Amy S Paller, Adelaide A Hebert, Mercedes E Gonzalez

|Jan 12, 2025
Tapinarof cream 1% once daily was well tolerated in adults and children with atopic dermatitis in two phase 3 randomized trials.

Linda Stein Gold, James Del Rosso, Benjamin D Ehst

|Jan 08, 2025
Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and Children.

Eric L Simpson, Adelaide A Hebert, John Browning

|Oct 29, 2021
Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics.

John E Jett, Michael McLaughlin, Mark S Lee

Pageof 1

Frequent Collaborators

4 joint publications

David S Rubenstein

3 joint publications

Anna M Tallman

2 joint publications

Glenn Tabolt

2 joint publications

Adelaide A Hebert